Update on Immunotherapeutics in the Management of Metastatic Melanoma

Bulir, David; Liang, Steven; O'Malley, Maureen; McWhirter, Elaine

Bulir, David; Liang, Steven; O'Malley, Maureen; McWhirter, Elaine.

Afiliação

Bulir D; Division of Dermatology, Department of Medicine, McMaster University, Hamilton, ON, Canada
Liang S; Medical Sciences Program, Faculty of Health Sciences, McMaster University, Hamilton, ON, Canada
O'Malley M; Division of Dermatology, Department of Medicine, McMaster University, Hamilton, ON, Canada
McWhirter E; Department of Oncology, McMaster University, Juravinski Cancer Centre, Hamilton, ON, Canada

Skin Therapy Lett ; 24(1): 8-11, 2019 Jan.

Article em En | MEDLINE | ID: mdl-30817881

Assuntos

Imunoterapia/métodos; Melanoma/tratamento farmacológico; Antígeno CTLA-4/antagonistas & inibidores; Humanos; Melanoma/patologia; Quinases de Proteína Quinase Ativadas por Mitógeno/antagonistas & inibidores; Metástase Neoplásica; Receptor de Morte Celular Programada 1/antagonistas & inibidores; Proteínas Proto-Oncogênicas B-raf/antagonistas & inibidores

Palavras-chave

immunotherapy; melanoma; update; checkpoint inhibitors; BRAF

Buscar no Google

Imprimir

XML

PubMed Links

Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Imunoterapia / Melanoma Limite: Humans Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Buscar no Google

Imprimir

XML

PubMed Links